Secondary Prevention

Known as: prevention secondary, Preventions, Secondary, Secondary Preventions 
Procedures or treatment processes designed to prevent complications (e.g., modifying a drug or surgical procedure to prevent complications).
National Institutes of Health

Related topics

Related topics

10 relations
ChemopreventionClinical Data Interchange Standards Consortium TerminologyEarly Intervention (Education)Early Therapy
(More)

Narrower (1)

Harm Reduction

Broader (1)

disease prevention

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective
BACKGROUND Women living in Africa experience the highest burden of cervical cancer. Research and investment to improve… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Primary prevention of cardiovascular disease with a Mediterranean diet.
BACKGROUND Observational cohort studies and a secondary prevention trial have shown an inverse association between adherence to… (More)
  • table 1
  • table 2
  • table 2
  • table 3
  • table 3
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Vorapaxar in the secondary prevention of atherothrombotic events.
BACKGROUND Thrombin potently activates platelets through the protease-activated receptor PAR-1. Vorapaxar is a novel antiplatelet… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.
S ince the 2001 update of the American Heart Association (AHA)/American College of Cardiology (ACC) consensus statement on… (More)
  • table 1
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.
CONTEXT Evidence suggests that more intensive lowering of low-density lipoprotein cholesterol (LDL-C) than is commonly applied… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention…
BACKGROUND Although it is generally accepted that lowering elevated serum levels of low-density lipoprotein (LDL) cholesterol in… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.
CONTEXT Observational studies have found lower rates of coronary heart disease (CHD) in postmenopausal women who take estrogen… (More)
Is this relevant?
Review
1998
Review
1998
Program integrity in primary and early secondary prevention: are implementation effects out of control?
We examined the extent to which program integrity (i.e., the degree to which programs were implemented as planned) was verified… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke
In 1988, we undertook a randomized, placebo-controlled, double-blind trial to investigate the safety and efficacy of low-dose… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease
In a prospective, randomised single-blinded secondary prevention trial we compared the effect of a Mediterranean alpha-linolenic… (More)
Is this relevant?